Bioactivity of Fungal Endophytes as a Function of Endophyte Taxonomy and the Taxonomy and Distribution of Their Host Plants by Higginbotham, Sarah J. et al.
Bioactivity of Fungal Endophytes as a Function of
Endophyte Taxonomy and the Taxonomy and
Distribution of Their Host Plants
Sarah J. Higginbotham1*, A. Elizabeth Arnold2, Alicia Iban˜ez1, Carmenza Spadafora4, Phyllis D. Coley1,3,
Thomas A. Kursar1,3
1 Smithsonian Tropical Research Institute, Panama, Republic of Panama, 2 School of Plant Sciences, University of Arizona, Tucson, Arizona, United States of America,
3Department of Biology, University of Utah, Salt Lake City, Utah, United States of America, 4 Instituto de Investigaciones Cientı´ficas y Servicios de Alta Tecnologı´a,
Panama, Republic of Panama
Abstract
Fungal endophytes – fungi that grow within plant tissues without causing immediate signs of disease – are abundant and
diverse producers of bioactive secondary metabolites. Endophytes associated with leaves of tropical plants are an especially
exciting and relatively untapped source of novel compounds. However, one major challenge in drug discovery lies in
developing strategies to efficiently recover highly bioactive strains. As part of a 15-year drug discovery project, foliar
endophytes were isolated from 3198 plant samples (51 orders, 105 families and at least 232 genera of angiosperms and
ferns) collected in nine geographically distinct regions of Panama. Extracts from culture supernatants of .2700 isolates
were tested for bioactivity (in vitro percent inhibition of growth, % IG) against a human breast cancer cell line (MCF-7) and
the causative agents of malaria, leishmaniasis, and Chagas’ disease. Overall, 32.7% of endophyte isolates were highly active
in at least one bioassay, including representatives of diverse fungal lineages, host lineages, and collection sites. Up to 17% of
isolates tested per assay were highly active. Most bioactive strains were active in only one assay. Fungal lineages differed in
the incidence and degree of bioactivity, as did fungi from particular plant taxa, and greater bioactivity was observed in
endophytes isolated from plants in cloud forests vs. lowland forests. Our results suggest that using host taxonomy and
forest type to tailor plant collections, and selecting endophytes from specific orders or families for cultivation, will markedly
increase the efficiency and efficacy of discovering bioactive metabolites for particular pharmaceutical targets.
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Introduction
Poor nutrition, a lack of clean water and proper sanitation,
global climate change, population aging, pollution, and the
emergence of drug-resistant pathogens together contribute to the
economic and human challenges of today’s global disease burden
[1] [2] [3] [4] [5]. As one of the leading causes of mortality
worldwide, cancer accounted for 7.6 million deaths in 2008 (13%
of all deaths in that year), and is expected to cause an estimated
13.1 million deaths annually by 2030. Neglected tropical diseases,
including leishmaniasis and Chagas’ disease, have a global disease
burden of on par with that of cancer (11.4% of annual deaths),
with malaria alone causing an estimated 655,000 deaths in 2008
(mostly of African children) [1] [2] [3]. Yet of all the drugs
approved between 1975 and 2004, only 1.3% (21 of 1556) were
developed specifically to treat neglected tropical diseases [4], and
treatments for cancer remain elusive in many cases [5].
After peaking during the ‘Golden Age of Antibiotics’ in the first
half of the 20th century, the pharmaceutical industry’s interest in
natural products and natural product structures as a source of drug
leads has gradually decreased [6]. However, drug discovery from
natural products is far from exhausted [7] [8] [9] [10]. New
methods for screening, new approaches for engineering novel
products from natural scaffolds, and the emergence of new
diseases argue for re-evaluation of drug discovery processes,
especially with regard to natural products from under-explored
sources [11]. As of 2005, approximately 22,000 bioactive
secondary metabolites from microorganisms had been described
in published works. About 8,600 (38%) of these are of fungal origin
[10], highlighting the biochemical richness of this diverse clade of
eukaryotes.
Endophytic fungi are microfungi that grow within plant tissues
without causing immediate symptoms of disease [12]. Some
provide benefits to their hosts including improved drought
tolerance (e.g., [13]), protection against pathogens (e.g., [14]),
enhanced growth (e.g., [15]), and defense against herbivory (e.g.,
[16] [17]). These features, combined with their immense diversity
(e.g., [14]), led drug discovery scientists to consider endophytic
fungi as sources of potentially interesting metabolites. Recent
reviews report the characterization of 138 secondary metabolites
from endophytic fungi before 2000 [18] with an additional 184
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reported by 2006 [19]. These metabolites encompass a diverse
range of structures including alkaloids [20], terpenoids [21],
quinones [22], and peptides, xanthones and phenols [23].
Bioactivity has been observed against cancer cell lines [24] [25],
pathogenic bacteria [26] [27] and fungi (e.g., [28]), and against
eukaryotic parasites such as the causal agents of malaria,
leishmaniasis and Chagas’ disease (e.g., [29] [30]).
One major challenge in drug discovery based on endophytic
fungi lies in developing efficient strategies to recover bioactive
strains. Strobel and Daisy [31] suggested that areas of high
biodiversity and with high numbers of endemic plant species may
hold the most potential for endophytes with novel chemistry.
Tropical forests are some of the most biodiverse ecosystems on
earth and tropical leaves are ‘biodiversity hotspots’ in terms of the
endophytes they harbor [32]. However, surveys of tropical
endophytes often yield very large culture libraries (e.g., [31]
[32]) for which broad screening can be inefficient and costly. Here
we use the results of a long-term drug discovery project to explore
how tailoring search criteria in tropical forests could significantly
enhance the discovery rate of bioactive foliar endophytes.
Despite the enormous natural wealth of the world’s tropical
forests, an ever-widening disparity exists between countries with
the financial resources to develop potential leads, and biodiversity-
rich countries with underdeveloped or developing economies that
may be unable to capitalize upon these important natural
resources [33]. The International Collaborative Biodiversity
Groups (ICBG; [34]) aim to link the infrastructure, training and
experience of academic and industrial organizations in developed
nations with the potential of the tropical countries that are
guardians to extraordinary biological and biochemical richness.
Specifically, ICBGs promote sustainable use of ecological wealth
while providing training and infrastructure to local communities
and maintaining a collaborative pipeline for drug development
and other applications [35].
For the past 15 years the Panama ICBG has applied ecological
insights to guide the search for novel, bioactive compounds from
terrestrial sources [36]. Diverse plants have been collected from
forests throughout Panama and their endophytic fungi have been
isolated in culture. Crude extracts have been tested for bioactivity
against a breast cancer cell line and the causal agents of malaria,
leishmaniasis and Chagas’ disease. Identification of these fungi
using molecular analysis provides an opportunity to look for broad
patterns in bioactivity not only at the genotype or strain level, but
at higher taxonomic levels that may in turn assist in focusing future
surveys. Specifically, our collection of tropical endophytes provides
a basis for assessing (1) the prevalence, variation, and specificity of
bioactivity in particular fungal lineages; (2) patterns of bioactivity
among endophytes from particular plant taxa; and (3) patterns of
bioactivity among endophytes from particular forest types (cloud
forest vs. lowland forest).
Here, we highlight the prevalence and specific bioactivity of
particular lineages of endophytes; reveal differences in bioactivity
among endophytes from particular plant lineages; and show for
the first time that endophytes obtained in cloud forests are more
likely to be bioactive than those obtained in proximate lowland
forests. Elucidating such patterns may help guide future drug
discovery efforts from tropical endophytic fungi, making the most
of limited resources and maximizing the chances of encountering
novel and active biochemistry.
Materials and Methods
Appropriate collection permits were obtained from Panama’s
Autoridad Nacional del Ambiente (ANAM) and healthy plant
tissues were collected in national parks throughout Panama
(Table 1). Leaves were stored in plastic bags and kept cool until
processed, usually within 24 hours. Plants were identified using
taxonomic keys and floras, as well as comparisons with collections
in the herbaria of the University of Panama (PMA) and Missouri
Botanical Garden (MO). Voucher specimens were deposited in
PMA, MO, and at the herbarium of the Smithsonian Tropical
Research Institute (SCZ).
Endophytic fungi were isolated from freshly collected, appar-
ently healthy leaves following [37] with slight modifications.
Within 48 h of collection, leaves were washed with tap water to
remove excess debris. Twelve pieces measuring ca. 2 mm62 mm
were cut from each leaf, surface sterilized by sequential immersion
in sodium hypochlorite (1%, 2 min) and ethanol (70%, 2 min) and
then rinsed with sterile, distilled water. Leaf pieces were laid on the
surface of 2% malt extract agar (MEA), a general medium that
promotes growth by diverse endophytes [14] [32] [38], in 100 mm
Petri dishes under sterile conditions. Dishes were sealed with
Parafilm, stored at room temperature, and checked daily for three
weeks for hyphal emergence. Emerging hyphae were cut from the
plate under sterile conditions and transferred to axenic culture on
2% MEA. Isolates were stored as living vouchers at room
temperature as agar plugs with mycelium in sterile distilled water
and have been archived in the collection of the ICBG at the
Smithsonian Tropical Research Institute in Panama (accessions
available on request).
Preparation of fungal extracts
A single plug was cut from actively growing, axenic mycelium,
transferred aseptically to fresh 2% malt extract agar, and
incubated at room temperature until mycelial growth covered at
least 50% of the agar surface. Fifteen agar plugs (each 5 mm
diameter) were cut with a sterile cork borer and transferred to
flasks containing 37 ml of 2% malt extract broth. Flasks were
incubated on an orbital shaker (28uC, 125 rpm) for one week.
Those that were growing were left for seven additional days under
the same conditions. Those that showed no visible signs of growth
were removed from the orbital shaker and left at room
temperature for three additional weeks to grow under static
conditions.
Each liquid culture with evident growth was mixed with an
equal volume of ethyl acetate (100%) and blended for 2 min at
9,000 rpm with a Polytron (Lauda-Brinkmann, Delran, NJ, USA).
The resulting mixture was filtered with Whatman filter paper, #1
and transferred to a separation funnel where it was extracted twice
with a 1:1 volume of ethyl acetate. The aqueous phase was
discarded and the organic layer was dried and stored at 280uC.
Bioassays
Crude organic extracts of fungal cultures were used in bioassays
against the causal agents of malaria (Plasmodium falciparum),
leishmaniasis (Leishmania donovani) and Chagas’ disease (Trypanosoma
cruzi), and against the human breast cancer cell line MCF-7.
Bioactivity of extracts, which were diluted in DMSO (10 mg/ml),
was measured as percent inhibition of growth (% IG) compared to
the negative control (DMSO with no extract; 0% IG). As a
measure of susceptibility of target cells to known drugs, for each
bioassay serial dilutions of the positive control were tested to
determine IC50 values (i.e., half of the maximum inhibitory
concentration). In some cases, % IG values obtained from
bioassays exceeded 100% or were lower than 0% IG, consistent
with enhancement of cell growth or destruction of existing cells
relative to controls. All chemical reagents used for bioassays were
obtained from Sigma Aldrich Inc. (Germany) unless specified.
Evidence from a Panamanian Drug Discovery Project
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The W2 strain of Plasmodium falciparum, obtained from the
Malaria Research and Reference Reagent Resource Center
(MR4, Manassas, VA, USA), was maintained in continuous
culture following [39]. Cultures consisted of a 2% haematocrit
suspension of O+ human erythrocytes in RPMI-1640 medium
supplemented with a gentamicin solution (Gibco, Invitrogen,
USA; 0.01 mg/mL), HEPES buffer (25 mM), NaHCO3 (Appli-
Chem, USA; 25 mM), and human serum (10%). Cultures were
supplied with a gas mixture consisting of 5% CO2, 5% O2, and
90% N2 and incubated in a cyclic incubator following [40]. Light
microscopy with Giesma stain [41] was used to estimate
parasitaemia and confirm parasite viability prior to bioassays.
For each bioassay, 180 ml of culture and 20 ml of each extract was
added to each well of a 96-well plate. The positive control
consisted of chloroquine diluted in RPMI-1640 medium (normal
IC50 value approximately 540 nM). After incubation for 48 h at
37uC, 50 ml of a PicoGreen cocktail (Invitrogen, USA) was added
to each well. Fluorescence was determined at 485 nm in a plate
reader (FL6800; BioTek Instruments Inc.) after 30 min.
The WR2801 strain of Leishmania donovani donovani (WR2801), a
generous gift of Max Grogl (Experimental Therapeutics Division,
Walter Reed Army Institute of Research, Silver Spring, MD,
USA), was maintained as promastigotes in culture at 26uC in
Schneider’s medium amended with a 1:2000 dilution of a
penicillin-streptomycin mix (10,000 units of penicillin and 10 mg
streptomycin/ml) and supplemented with sodium bicarbonate
(4.6 mM) and 20% Fetal Bovine Serum (FBS; Cellgro, USA) at
pH 7.2. Cells were transformed to amastigotes prior to bioassays
by lowering the pH to 5.5 with HCl and incubating at 30uC for
4 days. For each biosassay, 16106 cells were placed in each well of
a 96-well plate with 10 ml of extract in a final volume of 100 ml,
and incubated for 3 days. The positive control was amphotericin B
diluted in water (normal IC50 value 80–120 nM). A PicoGreen
cocktail was added at a 1:4 dilution and incubated at room
temperature for 5 min before fluorescence was measured at
485 nm (as above).
The Tulahuen LacZ clone C4 of Trypanosoma cruzi parasites
expressing b-galactosidase [42] was obtained from the American
Type Culture Collection (ATCC, Manassas, VA, USA) and
maintained in culture with RPMI-1640 supplemented with L-
glutamine (Gibco; 200 mM), HEPES buffer (25 mM), NaHCO3
(25 mM), 1:100 dilution of a penicillin-streptomycin mix (above)
and FBS (10%) at 37uC. On the day prior to the bioassay, 1.26104
Vero cells (ATCC) were seeded in a final volume of 100 ml of
culture medium/well in 96-well plates. After 24 h, Vero cells were
infected with 56104 parasite cells, which had been diluted in 50 ml
of culture medium. After an additional 24 h, 10 mg/ml of extract
was added to each well and incubated at 37uC for 120 h. The
positive control consisted of nifurtimox diluted in RPMI-1640
medium (normal IC50 value 0.5–1.5 mg/ml). Chlorophenol red-b-
D-galactopyranoside colorimetric substrate (CPRG, Roche Ap-
plied Science) was then added and allowed to react with the b-
galactosidase for 4.5 h at 37uC. Color intensity was read at
570 nm in a color plate reader (Sinergy HT, from BioTek
Instruments Inc., Winooski, VT).
The MCF-7 mammalian breast cancer cell line was obtained
from ATCC. On the day prior to the bioassay, 56103 cells were
seeded in a final volume of 100 ml/well in 96-well plates and
incubated with RPMI-640 supplemented with gentamicin
(0.05 mg/ml), L-glutamine (GIBCO; 2 mM), NaHCO3
(4.6 mM), HEPES buffer (25 mM), and FBS (10%) at 37uC. For
each bioassay, 100 ml of the extract was diluted in culture media,
Figure 1. Mean% IG by forest type.Mean % inhibition of growth of
the causative agents of malaria, leishmaniasis and Chagas’ disease, and
against the MCF-7 breast cancer cell line, as a function of forest type.
The analyses included fungi from all host plant orders with at least
three isolates in each of the two forest types. Asterisks denote
significant differences within a given assay.
doi:10.1371/journal.pone.0073192.g001
Table 2. Activity of crude extracts from fungal endophytes against Plasmodium falciparum (causative agent of malaria) in in vitro
assays, organized by fungal family.
Family (Order)
Mean %IG
(± SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Mycosphaerellaceae (Capnodiales) 28.3 (6.8) 14 4 28.6 High
Trichocomaceae (Eurotiales) 26.7 (7.4) 12 3 25 High
Magnaporthaceae (Magnaporthales) 26.6 (11.5) 5 1 20 High
Xylariaceae (Xylariales) 20.6 (4) 41 5 12.2 High
Amphisphaeriaceae (Xylariales) 17.1 (9.7) 7 0 0 Moderate
Valsaceae (Diaporthales) 16.1 (5.3) 23 2 8.7 Moderate
Phyllachoraceae (Phyllachorales) 14.9 (6.4) 16 2 12.5 Moderate
Botryosphaeriaceae (Botryosphaeriales) 8.1 (11.5) 5 0 0 Low
Nectriaceae (Hypocreales) 6.7 (11.5) 5 0 0 Low
Data indicate mean percent inhibition of growth (mean % IG) of parasite cells and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. The difference in mean % IG approached significance when the
qualitative activity levels were compared (F2,125 = 2.57; p = 0.0804).
doi:10.1371/journal.pone.0073192.t002
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added to the cells, and incubated for 48 h at 37uC. Cells were
fixed with tricholoroacetic acid (50%), rinsed with water, dried,
and treated with 100 ml of sulphorhodamine B (0.4%), which was
allowed to react for 15–30 min at 22uC. The positive control
consisted of adriamycin diluted in DMSO (normal IC50 value 20–
50 nM). The cells were then rinsed with trichloroacetic acid (1%),
dried, and treated with Tris-HCl (10 mM; pH 7) for 15 min.
Color intensity was read at 570 nm as described above.
Identification of fungi
Total genomic DNA was extracted from fresh mycelium
following [32]. The nuclear ribosomal internal transcribed spacers
and 5.8 s gene (ITS rDNA) were amplified using primers ITS1F or
ITS5 and ITS4 following [43]. PCR products were visualized
using SYBR green following electrophoresis on a 1% agarose gel
and positive amplicons were submitted to the University of
Arizona Genetics Core for cleanup, normalization, and bidirec-
tional Sanger sequencing. Sequences were assembled automati-
cally and bases called using phred and phrap [44] [45] with
orchestration by Mesquite [46], followed by manual editing in
Sequencher 4.5 (GeneCodes Corp.). Edited consensus sequences
were compared against the NCBI non-redundant database using
BLASTn to estimate taxonomic placement at high taxonomic
levels and submitted to GenBank under accession nos. KF435151-
KF436419. Because identification based only on BLAST matches
must be treated with caution [45] we used phylogenetic analyses
following [21] to provide stronger inference regarding taxonomic
affiliation. Genotype groups were determined by simultaneous
Table 3. Activity of crude extracts from fungal endophytes against Plasmodium falciparum (causative agent of malaria) in in vitro
assays, organized by fungal genus.
Genus (Family) Mean %IG (±SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Glomerella (Glomerellaceae) 50 (13) 5 3 60 High
Daldinia (Xylariaceae) 45.8 (14.5) 4 2 50 High
Ophioceras (Magnaporthaceae) 45.1 (16.8) 3 1 33.3 High
Phomopsis (Valsaceae) 35.6 (9.2) 10 3 30 High
Mycosphaerella (Mycosphaerellaceae) 31.9 (9.2) 10 4 40 High
Aspergillus (Trichocomaceae) 31.3 (14.5) 4 1 25 High
Xylaria (Xylariaceae) 26.4 (8.4) 12 3 25 High
Diaporthe (Diaporthaceae) 15.8 (13) 5 0 0 Moderate
Colletotrichum (Glomerellaceae) 12.7 (11) 7 0 0 Moderate
Parapleurotheciopsis (Xylariaceae) 11.1 (16.8) 3 0 0 Moderate
Camarops (Boliniaceae) 2.7 (16.8) 3 0 0 Low
Data indicate mean percent inhibition of growth of parasite cells (mean % IG) and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. Mean % IG varied significantly among activity levels (F2, 63 = 4.78;
p = 0.0117).
doi:10.1371/journal.pone.0073192.t003
Table 4. Activity of crude extracts from fungal endophytes against Leishmania donovani (causative agent of leishmaniasis) in in
vitro assays, organized by fungal family.
Family (Order) Mean %IG (± SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Nectriaceae (Hypocreales) 34.9 (7.9) 7 2 28.6 High
Trichocomaceae (Eurotiales) 21.9 (5.2) 16 2 12.5 High
Mycosphaerellaceae (Capnodiales) 20.4 (5.2) 15 3 20 High
Amphisphaeriaceae (Xylariales) 18.8 (7.9) 7 0 0 Moderate
Xylariaceae (Xylariales) 17.7 (3.1) 46 6 13.1 Moderate
Valsaceae (Diaporthales) 15.8 (3.8) 31 1 3.2 Moderate
Botryosphaeriaceae (Botryosphaeriales) 15.5 (7.9) 7 0 0 Moderate
Phyllachoraceae (Phyllachorales) 9.5 (5.1) 17 0 0 Low
Boliniaceae (Boliniales) 7.9 (9.4) 5 0 0 Low
Magnaporthaceae (Magnaporthales) 3.9 (9.4) 5 0 0 Low
Data indicate mean percent inhibition of growth of parasite cells (mean % IG) and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. Mean % IG varied significantly among activity levels (F2, 153 = 4.45;
p = 0.0132).
doi:10.1371/journal.pone.0073192.t004
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comparison of edited consensus sequences for all strains in
Sequencher 5.1 (Gene Codes Corp.) at 99% sequence similarity
[32] [38] [47], which provides estimates of genotypic richness
while allowing for a small amount of sequencing error [48].
Statistical analysis
Statistical analyses were performed using JMP 10.0 (SAS
Institute Inc., Cary, NC). Individual extracts and fungal genotypes
were considered ‘highly active’ if they caused 50% or greater
inhibition of growth ($50% IG). When multiple isolates of the
same genotype were examined, the genotype was considered
highly active if the mean % IG of all isolates of that genotype or
taxon was $50%. For analyses of variance based on host- and
fungal taxonomy, we calculated the average bioactivity of
endophytes belonging to each taxonomic group (e.g., family) and
then assigned categorical variables as follows: low (,10% mean
IG), moderate (10–20% mean IG), and high (.20% mean IG).
Significant differences among categories were determined using
Tukey’s post-hoc test (CI = 95%).
Results
Endophytes were isolated from 3198 plant collections repre-
senting 51 orders, 105 families and at least 232 genera of
angiosperms and ferns collected in national parks throughout
Panama. In sum, 3307 fungal endophytes were isolated; of these,
ITS rDNA was sequenced for 1144 isolates (Table 1). Endophytes
that were given taxonomic placement represented 291 genotypes
Table 5. Activity of crude extracts from fungal endophytes against Leishmania donovani (causative agent of leishmaniasis) in in
vitro assays, organized by fungal genus.
Genus (Family) Mean %IG (± SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Penidiella (Incertae sedis) 42.3 (13.4) 3 1 33.3 High
Diaporthe (Diaporthaceae) 33.6 (10.4) 5 1 20 High
Mycosphaerella (Mycosphaerellaceae) 23.2 (8.2) 8 2 25 High
Phomopsis (Valsaceae) 21.6 (7.3) 10 2 20 High
Aspergillus (Trichocomaceae) 19 (10.4) 5 0 0 Moderate
Xylaria (Xylariaceae) 17.8 (6.2) 14 1 7.1 Moderate
Daldinia (Xylariaceae) 17 (10.4) 5 1 20 Moderate
Colletotrichum (Glomerellaceae) 10.5 (8.8) 7 0 0 Moderate
Parapleurotheciopsis (Xylariaceae) 7.2 (13.4) 3 0 0 Low
Glomerella (Glomerellaceae) 7.1 (9.5) 6 0 0 Low
Ophioceras (Magnaporthaceae) 6.4 (13.4) 3 0 0 Low
Camarops (Boliniaceae) 6.3 (11.6) 4 0 0 Low
Data indicate mean percent inhibition of growth of parasite cells (mean % IG) and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. Mean % IG varied significantly among activity levels (F2, 70 = 4.21;
p = 0.0188).
doi:10.1371/journal.pone.0073192.t005
Table 6. Activity of crude extracts from fungal endophytes against Trypanosoma cruzi (causative agent of Chagas’ disease) in in
vitro assays, organized by fungal family.
Family (Order) Mean %IG (± SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Nectriaceae (Hypocreales) 34.9 (3.6) 6 5 83.3 High
Trichocomaceae (Eurotiales) 23.5 (2.1) 16 3 18.8 High
Valsaceae (Diaporthales) 22.1 (1.6) 33 6 18.2 High
Mycosphaerellaceae (Capnodiales) 18.1 (2.6) 16 2 12.5 Moderate
Amphisphaeriaceae (Xylariales) 13.6 (3.5) 7 0 0 Moderate
Phyllachoraceae (Phyllachorales) 13.5 (1.3) 17 2 11.8 Moderate
Magnaporthaceae (Magnaporthales) 13.1 (4.1) 5 0 0 Moderate
Xylariaceae (Xylariales) 12.8 (1.3) 45 2 4.4 Moderate
Botryosphaeriaceae (Botryosphaeriales) 12.4 (2.9) 8 0 0 Moderate
Data indicate mean percent inhibition of growth of parasite cells (mean % IG) and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. Mean % IG varied significantly among activity levels (F1,510 = 53.2;
p =,0.0001).
doi:10.1371/journal.pone.0073192.t006
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belonging to 124 genera, 45 families and 21 orders. In total, 2723
isolates were tested for bioactivity; of these, 2118 were tested in all
four assays, 571 isolates in three assays, 113 isolates in two assays,
and 20 isolates in just one assay.
Bioactivity was observed among endophytes from diverse fungal
lineages, host lineages, and collection sites. Overall, 32.7% of
isolates demonstrated $50% IG (i.e., were highly active) in at least
one bioassay. Of the 2118 isolates tested in all four bioassays, 0.6%
were highly active in four assays, 1.7% in three assays, 5.4% in two
assays, and 24.2% in only one assay. Approximately 4–17% of
isolates tested in each assay were highly active, with the greatest
frequency of highly active isolates observed in assays against P.
falciparum, the causal agent of malaria (Table 1).
Variation in bioactivity among fungal taxa
Analysis of all families and genera of fungi represented by at
least three genotypes revealed (1) significant variation in mean %
IG among fungal taxa in each bioassay and (2) that fungal lineages
with the highest mean % IG differed between bioassays (Tables 2–
9). Several fungal lineages were associated with little or no
bioactivity in any of the four bioassays (Table 10).
Variation in bioactivity at the level of host plant taxa
We evaluated the mean % IG of endophytes from all plant
families from which at least three endophyte genotypes were
isolated. Mean % IG differed significantly among endophytes
representing various plant families. Host plant families associated
with endophytes that displayed the highest mean % IG also
Table 7. Activity of crude extracts from fungal endophytes against Trypanosoma cruzi (causative agent of Chagas’ disease) in in
vitro assays, organized by fungal genus.
Genus (Family) Mean %IG (± SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Phomopsis (Valsaceae) 30.4 (4.1) 11 2 18.2 High
Diaporthe (Diaporthaceae) 23.6 (5.5) 6 1 16.7 High
Aspergillus (Trichocomaceae) 18.9 (6) 5 0 0 High
Penidiella (Incertae sedis) 17.8 (7.8) 3 0 0 Moderate
Colletotrichum (Glomerellaceae) 16.1 (5.1) 7 0 0 Moderate
Mycosphaerella (Mycosphaerellaceae) 16 (4.1) 11 0 0 Moderate
Xylaria (Xylariaceae) 15 (3.6) 14 1 7.1 Moderate
Glomerella (Glomerellaceae) 13.7 (6) 5 0 0 Moderate
Daldinia (Xylariaceae) 11.8 (6.8) 4 0 0 Low
Camarops (Boliniaceae) 11.2 (7.8) 3 0 0 Low
Ophioceras (Magnaporthaceae) 10.8 (7.8) 3 0 0 Low
Data indicate mean percent inhibition of growth of parasite cells (mean % IG) and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. Mean % IG varied significantly among activity levels (F1,181 = 4.16;
p = 0.0428).
doi:10.1371/journal.pone.0073192.t007
Table 8. Activity of crude extracts from fungal endophytes against MCF-7 breast cancer cell line in in vitro assays, organized by
fungal family.
Family (Order) Mean %IG (± SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Nectriaceae (Hypocreales) 38.7 (8.1) 6 2 33.3 High
Trichocomaceae (Eurotiales) 24 (4.8) 17 4 23.5 High
Valsaceae (Diaporthales) 15.7 (3.5) 32 3 9.4 Moderate
Xylariaceae (Xylariales) 13.3 (2.9) 45 3 6.7 Moderate
Amphisphaeriaceae (Xylariales) 8 (7.5) 7 0 0 Low
Magnaporthaceae (Magnaporthales) 7.7 (8.9) 5 0 0 Low
Phyllachoraceae (Phyllachorales) 6 (4.7) 17 0 0 Low
Botryosphaeriaceae (Botryosphaeriales) 5 (6.6) 9 0 0 Low
Boliniaceae (Boliniales) 4.6 (8.9) 5 0 0 Low
Mycosphaerellaceae (Capnodiales) 3.9 (4.8) 17 0 0 Low
Data indicate mean percent inhibition of growth of parasite cells (mean % IG) and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. Mean % IG varied significantly among activity levels (F2, 160 = 11.12;
p =,0.0001).
doi:10.1371/journal.pone.0073192.t008
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differed among bioassays (Tables S1 – S4 in File S1). Several plant
families harbored endophytes that had little or no bioactivity in the
four bioassays (Table 10).
Differences in bioactivity as a function of forest type
Because the majority of our sampling was conducted in cloud
forest and lowland humid forest (Table 1), we focused on those two
forest types, and only considered endophytes represented by at
least three isolates from each plant taxa. We found that cloud
forest endophytes had significantly higher mean % IG than
lowland humid forest endophytes against both P. falciparum (F29,
665 = 8.54, p = 0.0001) and L. donovani (F16,931 = 2.07, p = 0.0079) in
vitro. No meaningful differences in mean % IG were observed
against T. cruzi or MCF-7 breast cancer cells in vitro (Figure 1).
To distinguish whether these significant differences reflected the
presence of different major lineages of fungi in cloud vs. lowland
forest, or different levels of activity among the same major lineages
in these forests, we examined the most prevalent fungal orders that
were identified in both forest types, and for which sufficient
bioassay results were available. Three orders fit these criteria:
Capnodiales, Dothideales, and Phyllachorales. In each case, we
observed a trend for higher activity, or significantly higher activity,
in at least one bioassay by cloud forest strains relative to strains
belonging to the identical order from lowland humid forests (data
not shown). We further examined the bioactivity of the most
common fungal genotypes that occurred in both cloud forests and
lowland humid forests. Analyses were restricted to genotypes that
were represented by at least 10 isolates, were obtained from both
forest types, and were assessed for bioactivity in at least two assays.
Three genotypes fit these criteria. In all three, strains from cloud
forests demonstrated significantly greater bioactivity than conspe-
cifics from lowland forest in at least one bioassay (Z-tests for exact
means; alpha = 0.05; p,0.05 in all cases).
Discussion
The enormous cost of drug development is a clear incentive for
pharmaceutical companies to disregard all but the most financially
viable lead compounds. However, the dwindling number of
medications reaching the market is putting intense pressure on the
industry to innovate [6]. Combinatorial chemistry, coupled with
the new high-throughput screening (HTS) technology of the early
1990’s, seemed to promise a new era of drug discovery success
[49]. However, from 1981 to 2010 only one de novo combinatorial
compound was approved by the FDA [50]. Meanwhile, natural
products and natural product structures, in particular those from
microbial sources, continue to be reported in considerable
numbers [51]. Many microorganisms appear to be intrinsically
capable of producing far more natural products than have been
observed in the lab [52], thus representing a rich source of novel,
bioactive metabolites. Tropical fungal endophytes are of particular
interest as they exhibit remarkable abundance and diversity, and
communities differ markedly at regional and large geographic
scales [32] [37]. Furthermore, endophytes are thought to use
chemical compounds to mediate interactions with competitors and
other antagonists [53] [54]. Our collections across a diversity of
biomes in Panama suggest taxonomic and ecological attributes
that might enhance our ability to discover bioactive compounds
for particular disease targets.
Our analyses show for the first time that endophytes isolated
from plants in cloud forests are considerably more bioactive in
assays against P. falciparum and L. donovani than those isolated from
plants in lowland humid forests (Figure 1). Our results suggest that
even when the same fungal taxa are found in lowland forests, those
isolated from cloud forests demonstrate greater bioactivity. We
hypothesize that the moist conditions of cloud forests may enhance
the colonization of leaves by endophytes (as for epiphylls; [55]): the
frequency with which endophytes are isolated from tissues tends to
be negatively associated with desiccation and ultraviolet radiation
[56] [57], and positively associated with leaf lifetime and humidity
Table 9. Activity of crude extracts from fungal endophytes against MCF-7 breast cancer cell line in in vitro assays, organized by
fungal genus.
Genus (Family) Mean %IG (± SE)
Fungal
Genotypes
Examined
Highly Active
Genotypes
% Highly Active
Genotypes Activity Level
Aspergillus (Trichocomaceae) 41.6 (7.5) 5 3 60 High
Xylaria (Xylariaceae) 20.2 (4.5) 14 1 7.1 High
Phomopsis (Valsaceae) 18.8 (5) 11 0 0 Moderate
Daldinia (Xylariaceae) 10.2 (7.5) 5 0 0 Moderate
Guignardia (Botryosphaeriaceae) 8.4 (9.6) 3 0 0 Low
Ophioceras (Magnaporthaceae) 8.4 (9.6) 3 0 0 Low
Mycosphaerella (Mycosphaerellaceae) 6.3 (5) 11 0 0 Low
Camarops (Boliniaceae) 5.5 (8.4) 4 0 0 Low
Colletotrichum (Glomerellaceae) 4 (6.3) 7 0 0 Low
Glomerella (Glomerellaceae) 3.5 (6.8) 6 0 0 Low
Diaporthe (Diaporthaceae) 3.4 (7.5) 5 0 20 Low
Phoma (Incertae sedis) 2.6 (9.6) 3 0 0 Low
Parapleurotheciopsis (Xylariaceae) 1.6 (9.6) 3 0 0 Low
Data indicate mean percent inhibition of growth of parasite cells (mean % IG) and standard error, the number of fungal genotypes examined, the number and percent
of those genotypes that are highly active (i.e., $50% IG), and a qualitative statement of activity level. Mean % IG varied significantly among activity levels (F2,78 = 7.18;
p = 0.0014).
doi:10.1371/journal.pone.0073192.t009
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[14] [54]. The seasonal lowland forests we examined have greater
seasonal drought stress and UV irradiance, and a higher
proportion of seasonally deciduous species, than the cloud forests
we considered here. Future studies linking bioactivity in vitro with
bioactivity in symbiosis may be especially illuminating with regard
to efficient recovery of bioactive endophytes.
Our analyses also highlight taxonomic groups of plants that
harbored (1) a high percentage of highly active endophytes, and (2)
endophytes with high mean % IG in several bioassays (Tables S1 –
S4 in File S1). For example, fungi isolated from the plant family
Araceae (Alismatales) had a high percentage of highly active
genotypes and were associated with moderate to high mean % IG
against L. donovani, T. cruzi and the MCF-7 breast cancer cell line.
Fungi isolated from the plant family Fabaceae (Fabales) had a high
percentage of highly active genotypes and were associated with
moderate to high mean % IG against P. falciparum and the MCF-7
breast cancer cell line.
The bioactivity profiles of several fungal lineages suggested
compounds with strong and specific bioactivity (Tables 2–9).
Specific bioactivity, defined as high inhibition of growth of one
type of target organism with little or no activity against others, is of
particular interest in drug discovery: it suggests the presence of
compounds that have specific modes of action as opposed to highly
toxic compounds that are often of little use as medication [58].
Extracts from fungi of the family Mycosphaerellaceae (Capno-
diales) had moderate to high mean % IG against the parasites P.
falciparum, L. donovani and T. cruzi, but had particularly low mean %
IG against the MCF-7 breast cancer cell line. In contrast, under
the conditions used here, extracts from fungi of the family
Trichocomaceae (Eurotiales) had high mean % IG against the
three tropical disease parasites as well as against the MCF-7 breast
cancer cell line, suggesting the presence of non-specific and highly
toxic compounds. As such, fungi from this family might be
excluded from future scale-up efforts for greatest efficiency.
Tropical fungal endophytes are a well-documented source of
interesting bioactive metabolites and, with their immense biodi-
versity, hold enormous potential for future drug discovery [59].
Here, we used only a single isolation medium and isolation
approach to obtain endophytes from photosynthetic tissues; thus it
is likely that additional genotypes with specialized growth
requirements, or that inhabit other tissues, would be discovered
through further research. Similarly, additional bioactivity might be
observed under different growth conditions, as secondary metab-
olite production is strongly influenced by factors such as substrate
type, temperature, and other factors [60]. However, our focus on
foliar endophytes and the methods outlined here has been fruitful:
the Panama ICBG has had much success discovering novel
bioactive compounds from these organisms (e.g., [61] [62] [63]).
Overall, more than 32% of our fungal isolates were active in at
least one of the four bioassays. However, by analyzing .10 years
of collection and bioassay data we have shown that by tailoring
certain selection criteria we could significantly improve our
chances of encountering highly bioactive fungi. For example, we
observed that 16.9% of fungal genotypes screened in our work
were highly active against P. falciparum. If only those fungi isolated
from host plants of the family Fabaceae (Fabales) are considered,
the prevalence of highly active isolates increases to 22.2%. If only
host plants of the order Fabales that were collected from cloud
forests are considered, the prevalence of highly active isolates
increases to 53.1% – a more than three-fold improvement that
could dramatically increase the chances of finding interesting
bioactive molecules while maximizing limited resources. Analyses
of this type, although not yet vetted for predictive power in otherT
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forests, are important for establishing guidelines to enhance the
efficacy and efficiency of future bioprospecting efforts.
Supporting Information
File S1 Supporting Information file that contains. Table
S1. Activity of fungal endophytes against Plasmodium
falciparum (causative agent of malaria) in in vitro
assays, organized by host plant family. Data indicate mean
percent inhibition of growth (mean % IG) of parasite cells and
standard error, the number of plant species and fungal genotypes
examined, the number and percent of fungal genotypes that are
highly active (i.e.$50% IG), and a qualitative statement of activity
level. Mean % IG varied significantly between activity levels
(F2,137 = 4.67; p = 0.0108). Table S2. Activity of fungal
endophytes against Leishmania donovani (causative
agent of leishmaniasis) in in vitro assays, organized by
host plant family. Data indicate mean percent inhibition of
growth (mean % IG) of parasite cells and standard error, the
number of plant species and fungal genotypes examined, the
number and percent of fungal genotypes that are highly active (i.e.
$50% IG), and a qualitative statement of activity level. Mean %
IG varied significantly between activity levels (F2,194 = 4.86;
p = 0.0087). Table S3. Activity of fungal endophytes
against Trypanosoma cruzi (causative agent of Chagas’
disease) in in vitro assays, organized by host plant
family. Data indicate mean percent inhibition of growth (mean
% IG) of parasite cells and standard error, the number of plant
species and fungal genotypes examined, the number and percent
of fungal genotypes that are highly active (i.e. $50% IG), and a
qualitative statement of activity level. Mean % IG varied
significantly between activity levels (F1,181 = 4.20; p = 0.0428).
Table S4. Activity of fungal endophytes against MCF-7
breast cancer cells in in vitro assays, organized by host
plant family. Data indicate mean percent inhibition of growth
(mean % IG) of parasite cells and standard error, the number of
plant species and fungal genotypes examined, the number and
percent of fungal genotypes that are highly active (i.e. $50% IG),
and a qualitative statement of activity level. Mean % IG varied
significantly between activity levels (F2,171 = 4.49; p = 0.0125).
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